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GENETIC DISORDERS – DEVELOPMENT
Expression of mitogen-activated protein kinases in human
renal dysplasia
SAYU OMORI, RYUJI FUKUZAWA, MARIKO HIDA, and MIDORI AWAZU
Departments of Pediatrics and Pathology, Keio University School of Medicine, Tokyo, Japan
Expression of mitogen-activated protein kinases in human re- children [1]. It is characterized by dysplastic tubules con-
nal dysplasia. nected to cysts and surrounding undifferentiated tissue.
Background. We previously reported that the expression of
Immediately around dysplastic tubules are collars of fi-mitogen-activated protein kinases (MAPKs) is developmen-
bromuscular-like cells. Renal dysplasia is thought to betally regulated. Dysregulation of MAPKs may lead to kidney
malformation. Thus, we investigated the expression of MAPKs a developmental aberration of mesenchymal-epithelial
in human renal dysplasia, one of the most common kidney transformation [2]. Thus, it is hypothesized that dysplas-
malformations.
tic tubules represent malformed collecting ducts whileMethods. Prenatal (gestational ages 20 to 36 weeks, N  6)
the surrounding tissues represent the mesenchyme thatand postnatal (2 years old, N  1) dysplastic kidneys, and
normal kidneys (gestational ages 19 to 34 weeks, N  4) were has failed to differentiate into nephrons [3, 4]. Obstruc-
examined. Immunohistochemical studies were performed using tion of the urinary tract often accompanies dysplasticantibodies against extracellular signal-regulated kinase (ERK),
kidneys, and is suggested to be one of the etiologic fac-p38 MAPK (p38), c-Jun N-terminal kinase (JNK), phospho-
MAPKs (P-MAPKs), and proliferating cell nuclear antigen tors. In animal experiments, prenatal obstruction of uri-
(PCNA). Apoptosis was detected by the TUNEL method. nary tract reproduces dysplastic changes similar to hu-
Results. In dysplastic kidneys, proliferation was prominent
man renal dysplasia [5, 6]. A disturbance of the normalin dysplastic tubules and also found in cyst epithelia. TUNEL
pattern of ureteric bud branching also has been sug-staining was detected in dysplastic tubules and cysts, and occa-
sionally in undifferentiated cells. p38 and anti-phospho-p38 gested to be the cause. The mechanism of maldevelop-
(P-p38) were strongly expressed in dysplastic epithelia, but not ment of mesenchyme into nephrons, however, has not
detected in normal kidneys at any stage examined. On the
been elucidated. Increased cell proliferation in dysplasticother hand, JNK and P-JNK were positive in tubular epithelia
of normal kidneys, whereas their expression was barely detect- epithelia as well as prominent apoptosis in undifferenti-
able in dysplastic tubules and cysts. ERK was expressed in all ated mesenchyme have been reported, suggesting that
tubular segments, and P-ERK was detected in distal tubules deregulation of cell survival plays pivotal roles in theand collecting ducts of normal kidneys. Dysplastic kidney epi-
pathogenesis of dysplastic kidneys [7, 8].thelia stained exclusively positive for ERK and P-ERK.
Conclusions. p38 is ectopically expressed, and JNK is down- Mitogen-activated protein kinases (MAPKs) are en-
regulated in dysplastic kidney epithelia. Furthermore, dys- zymes that play important roles in cell proliferation, dif-
plastic epithelia are exclusively positive for ERK and P-ERK.
ferentiation, and apoptosis. We previously reported thatActivated p38 and ERK may mediate hyperproliferation of
MAPKs are developmentally regulated in rat kidney [9].dysplastic tubules resulting in cyst formation, whereas down-
regulated JNK expression may be the cause or the result of Thus, extracellular signal-regulated kinase (ERK) and
an undifferentiated state of dysplastic epithelia. p38 MAPK (p38) are strongly expressed in the devel-
oping kidney, whereas c-Jun N-terminal kinase (JNK)
is detected predominantly in the adult kidney. The inhi-Renal dysplasia is one of the most common kidney
bition of ERK or p38 by specific inhibitors in organ-malformations that lead to chronic renal failure in young
cultured kidneys resulted in disturbed nephron forma-
tion, ureteric bud growth, and kidney growth [10]. These
Key words: extracellular signal-regulated kinase, p38 mitogen-acti- results point to important roles of MAPKs in renal devel-
vated protein kinase, c-Jun N-terminal kinase, kidney malformation,
opment. Dysregulated MAPKs, therefore, may lead todevelopment.
kidney malformation. In the present study, we examined
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Table 1. Samples
Gestational age Sex Renal and associated pathology
Normal kidneys weeks
19 M Spontaneous miscarriage, body stalk anomaly
21 Ambiguous Abortion for conjoined twin
28 M Abortion for multiple anomalies with contralateral multicystic dysplasia
34 M Osteogenesis imperfecta
Dysplastic kidneys weeks
20 Ambiguous Spontaneous miscarriage, Potter syndrome
22 M Abortion for bilateral multicystic dysplasia
28 M Abortion for multiple anomalies with ipsilateral multicystic dysplasia
28 F Abortion for bilateral multicystic dysplasia, right megaureter and ectopia
33 M Abortion for bilateral multicystic dysplasia
36 Unknown Abortion for bilateral multicystic dysplasia
Postnatal 2 years F Multiple anomaly with ipsilateral multicystic dysplasia
METHODS anol for 15 minutes. To unmask antigens, slides were
boiled 100C for 10 minutes in 10% citrate buffer (pHSpecimens
6.0)/methanol. Sections were incubated with antibodies
Dysplastic and control kidneys were obtained from
against PCNA (dilution 1:100), ERK (dilution 1:200),
fetuses of spontaneous miscarriages and abortions per-
p38 (dilution 1:200), JNK (dilution 1:50), MKP-1 (dilu-
formed for severe abnormalities. Dysplastic kidneys
tion 1:100), P-ERK (dilution 1:100), P-p38 (dilution
from gestational ages 20 weeks to 36 weeks (N  6) and
1:100), or P-JNK (dilution 1:100) at 4C for overnight.
normal kidneys from gestational ages 19 to 34 weeks
After incubating with secondary antibody at a concentra-
(N  4) were examined. One dysplastic kidney was har-
tion of 1:100, immunoreaction products were developed
vested at age 2 years at autopsy. Details of these speci- using 3,3-diaminobenzidine (DAB) as the chromogen,
mens are listed in Table 1. Kidney pathology was classi- with standardized development times. Sections were
fied by gross morphology and routine histopathology. then counterstained with hematoxylin acetate or methyl
The dysplastic samples all had dysplastic tubules and green. Positive controls (brain for ERK, JNK, and MKP-1,
undifferentiated mesenchymal tissue. and bone marrow for p38) were run simultaneously. Neg-
ative controls included adding saturating titers of antigenReagents
(for ERK), omitting the primary antibody or substitution
Anti-ERK antibody (Erk1/2-CT, rabbit polyclonal of the primary antibody with rabbit serum.
IgG) was from Upstate Biotechnology (Lake Placid, NY,
USA). Anti-p38 (C-20), anti-JNK (FL), and anti-MKP-1 Detection of apoptosis
(V-15) antibodies were from Santa Cruz Biotechnology Cells undergoing apoptosis were identified using an in
(Santa Cruz, CA, USA). Monoclonal anti-ERK acti- situ DNA labeling method. Paraffin embedded sections
vated (P-ERK) was from Sigma (St Louis, MO, USA); were deparaffinized, and terminal deoxynucleotide trans-
anti-phospho-p38 (P-p38) and anti-phospho-JNK (P-JNK) ferase-mediated nick-end labeling (TUNEL) staining was
antibodies were from New England Biolab (Beverly, performed using the ApopTag kit. Sections were coun-
MA, USA). A monoclonal antibody specific for prolifer- terstained with methyl green. TdT was omitted from the
ating cell nuclear antigen (PCNA)/cyclin, peroxidase-con- staining procedure in negative controls.
jugated rabbit anti-mouse and peroxidase-conjugated
swine anti-rabbit immunoglobulins, and DAKO Pro-
RESULTStein K Enzyme Digestion were from DAKO A/S (Glos-
trup Denmark). ApopTag Peroxydase In Situ Apopto- The results are summarized in Table 2. There was
sis Detection Kit was from Intergen Company (Purchase, no difference in the expression patterns in preterm and
NY, USA). postnatal dysplastic kidneys.
Immunohistochemistry PCNA
After fixation in 10% formalin, kidneys were em- In normal kidneys, PCNA positive cells were most
bedded in paraffin. Immunohistochemical staining was abundant in the nephrogenic zone immediately under
performed on serial sections 4 m thick, using enzyme- the renal capsule, which included undifferentiated mesen-
labeled antibody method. Paraffin sections were deparaf- chymal cells, condensing mesenchyme, vesicles, comma-
finized and rehydrated. Endogenous peroxide activity and S-shaped bodies, and tips of ureteric bud branches
(Fig. 1A). Tubular epithelial cells in the deep corticalwas quenched by incubating sections in 0.3% H2O2/meth-
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Table 2. Expression of MAPKs and MKP-1 in normal and dysplastic kidneys
p38 P-p38 JNK P-JNK ERK P-ERK MKP-1 PCNA TUNEL
Normal kidneys
Immature tubules/UB tips — — — —     (50%)  (rare)
Mature tubules/CD — —   (distal, CD)   (distal, CD) —  (rare) —
Uninduced mesenchyme — — — —   —  (20%)  (rare)
Interstitium — — — — — — — — —
Glomeruli — —  (rare)  (rare)  (rare)  (rare) —  (rare)  (rare)
Dysplastic kidneys
Dysplastic tubules   — —     (40%)  (90%)
Cyst epithelia   — —     (15%)  (80%)
Collarettes/undifferentiated cells   (rare) — —   (rare)   (rare)  (35%)
Signs denote: (—) no immunoreactivity; () weak immunoreactivity; ( to ) increasing intensity of staining present in the majority of cells in the designated
population. ‘Rare’ indicates that 10% of cells showed positive immunostaining. Parenthesis indicates the percentage of cells positive for PCNA or TUNEL.
Abbreviations are: MAPKs, mitogen-activated protein kinases; MKP-1, MAPK phosphatase-1; p-38, p-38 MAPK; P-p38, phospho-p-38 MAPK; JNK, c-jun N-terminal
kinase; ERK, extracellular signal-regulated kinase; PCNA, proliferating cell nuclear antigen; TUNEL, terminal deoxynucleotide transferase-mediated nick-end
labeling; UB, ureteric bud; CD, collecting ducts.
layer were occasionally stained. As previously reported, kidneys, P-ERK was strongly and exclusively positive in
PCNA was stained intensely in dysplastic tubules and diseased epithelia (Fig. 2L).
weakly in cyst epithelia of dysplastic kidneys (Fig. 1B).
MKP-1
TUNEL staining Mitogen-activated protein kinase phosphatase-1 was
In normal kidneys, TUNEL staining was faintly detect- faintly expressed in ureteric buds of control kidneys (Fig.
able in the nephrogenic zone (Fig. 1C). In dysplastic 2M). Dysplastic epithelia and undifferentiated cells to a
kidneys, apoptosis was prominent in dysplastic tubules lesser extent expressed MKP-1 (Fig. 2N).
and cysts, and occasionally found in surrounding undif-
ferentiated cells (Fig. 1D). These findings are in accord
DISCUSSIONwith a previous report [7].
The present study demonstrates that the expression
p38 of MAPKs is dysregulated in human renal dysplasia. p38
and ERK, which are thought to mediate proliferation,p38 MAPK and P-p38 were not detected in control
are up-regulated or activated, while JNK is down-regu-kidneys at any stage examined (Fig. 2 A, C). In striking
lated in dysplastic epithelia. The abnormal expression ofcontrast, both p38 and P-p38 were intensely stained in
MAPKs is associated with increased PCNA expressiondysplastic epithelia (Fig. 2 B, D). p38 expression was
in dysplastic epithelia as previously reported [8]. Thus,detected also in areas of undifferentiated cells.
dysregulated MAPKs may mediate hyperproliferation
JNK of dysplastic tubules leading to cyst formation.
We previously reported that p38 was expressed in theContrary to p38, JNK was expressed in all the seg-
developing rat kidney [9]. The expression of p38 was mostments of mature tubules in control kidneys (Fig. 2E).
intense in the kidney at embryonic day 14 and detectedP-JNK was faintly stained in distal tubules (Fig. 2G)
up to postnatal day 1. It localized in non-induced mesen-and collecting ducts (not shown) of control kidneys. In
chyme, condensing mesenchyme and ureteric buds. Thecontrast to control kidneys, JNK and P-JNK were not
level and localization of phosphorylated p38 correlateddetected in diseased epithelia of dysplastic kidneys in-
with those of p38. In the normal human kidney fromcluding the postnatal specimen (Fig. 2 F, H).
gestational ages 19 to 34 weeks, p38 was not detected,
ERK probably because rat and human kidneys develop over
different time frames. In humans, nephrogenesis ceasesExtracellular signal-related kinase expression was
at 34 weeks, whereas nephron formation continues upweak in immature tubules and non-induced mesenchyme
to postnatal day 8 in rats. In contrast to normal kidneysin the nephrogenic zone, but was detected intensely in
of comparable gestational ages, dysplastic kidneys ex-distal tubules, collecting ducts, and to a lesser extent in
pressed p38 and phosphorylated p38. The dysplastic kid-proximal tubules of control kidneys (Fig. 2I). Dysplastic
ney harvested from a two-year-old patient also showedtubules and cysts stained positive for ERK (Fig. 2J).
persistent expression of p38. These results suggest thatSurrounding undifferentiated cells also expressed ERK.
ectopically expressed p38 in dysplastic kidneys may beP-ERK was detected in distal tubules (Fig. 2K) and col-
lecting ducts (not shown) of control kidneys. In dysplastic involved in high rate cell turnover and undifferentiated
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Fig. 1. Distribution of proliferating cells and apoptosis in normal and
dysplastic kidneys. Sections A and C are from a normal 21-week gesta-
tion kidney. D and E are from a 22-week gestation dysplastic kidney.
(A, B) Immunohistochemical localization of proliferating cell nuclear
antigen (PCNA) staining (200). In the normal kidney, PCNA staining
is most abundant in the nephrogenic zone immediately under the renal
capsule (A). Condensing mesenchyme, vesicles, S-shaped bodies, and
tips of ureteric bud branches are most intensely stained, but undifferenti-
ated mesenchymal cells are also labeled. Tubular epithelial cells in the
deep cortical layer are occasionally stained. Dysplastic tubules, and to
a lesser degree cyst epithelia and surrounding undifferentiated cells are
positive for PCNA (B). (C, D, E) Labeling of apoptotic cells using
TUNEL assay (200). In the normal kidney, faint staining is observed
in the nephrogenic zone (C). In the dysplastic kidney, apoptosis is
detected in dysplastic tubules and cystic epithelia (D). Numerous undif-
ferentiated cells around dysplastic tubules and cysts are also TUNEL-
positive (D). (E) The dysplastic kidney incubated in the absence of
terminal deoxynucleotidyl transferase (TdT).
states. Although p38 has been implicated in apoptosis, Sodhi et al detects only p38	. Thus, p38	 probably has
proliferative action on renal cells.our previous study suggested that its expression cor-
related with proliferation rather than apoptosis in the In our previous study in the rat, ERK was expressed
throughout the stages during kidney development, withdeveloping kidney [9]. Furthermore, a p38 inhibitor
SB203580 suppressed metanephros growth in organ cul- the highest expression and activation levels in the fetal
kidney [9]. In the normal human fetal kidney, ERK wasture [10]. In addition, Sodhi, Batlle and Sahai demon-
strated that p38-mediated hypoxia induced cell prolifera- expressed in all mature tubular segments, and phosphor-
ylated ERK was detected in distal tubules and collectingtion in mesangial cells [11]. While several p38 isoforms
are known to exist [12], the antibody used by us and ducts. In the dysplastic kidney, diseased epithelia were
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exclusively positive for ERK and phosphorylated ERK. loss of JNK expression may be the result of an immature
and undifferentiated state of the epithelial cells.An explanation for the expression of phosphorylated
ERK in dysplastic epithelia might be that they are of Although JNK as well as p38 have been implicated in
apoptosis, we found no correlation between their expres-ureteric bud/collecting duct lineage. PAX2 and galec-
tin-3, markers for this lineage, have been shown to be sion and apoptosis in either normal or dysplastic kidneys.
Of note, it has been suggested that the default pathwaypresent in dysplastic epithelia [8, 13]. Previous studies,
however, demonstrated that cysts in dysplastic kidneys for developing renal cells is to undergo apoptosis. Only
cells rescued by growth factors can survive. Apoptosiswere derived from Bowman’s capsule, proximal tubules
as well as from collecting ducts [14]. Thus, the expression by the removal of growth factors is mediated by the
phosphoinositide 3-kinase/Akt pathway [24]. Thus, apo-of phosphorylated ERK suggests a high rate of prolifera-
tion rather than its origin, in view of the known action ptosis seen in the developing or dysplastic kidney may
be mediated by pathways that do not involve JNK or p38.of ERK to promote proliferation. Winyard et al demon-
strated that dysplastic epithelia maintain a high rate of While total and phosphorylated forms of p38 were
expressed similarly, those of JNK or ERK were differen-proliferation along with the expression of PAX2, a po-
tentially oncogenic transcription factor, and BCL2, an tially expressed. Thus, phosphorylated JNK or ERK was
detected only in distal tubules and collecting ducts. Aanti-apoptotic factor [8]. The authors speculated that
these genes might drive the proliferation of dysplastic similar pattern of differential expression of total and
phosphorylated JNK or ERK was previously observedcysts [8]. The present study suggests that p38 and/or
ERK mediate hyperproliferation of dysplastic epithelia. in rat adult kidneys [9]. The significance of these findings
remains to be determined.Whether ERK or p38 is involved in the regulation of
PAX2 or BCL2, or downstream events of these genes In our previous study, MKP-1 was expressed in the
embryonic kidney colocalizing with p38 and ERK [9].remains to be clarified.
In addition to PAX2 and BCL2, several growth fac- Undifferentiated cells around dysplastic tubules express
p38, ERK, and MKP-1, displaying an expression patterntors, their receptors, and adhesion molecules are ex-
pressed differently in dysplastic kidneys, as reviewed that mimicked the pattern seen in undifferentiated mes-
enchyme of the rat fetal kidney. These findings suggestrecently by Woolf and Winyard [2]. These growth factors
include hepatocyte growth factor (HGF) and its receptor a role of MKP-1 as a regulator of ERK and p38 in
dysplastic kidneys. In normal human kidneys examinedMET [15], insulin-like growth factor (IGF) [16], galectin
3 [13], and 	 integrin subunits [17]. We have demon- in the present study, MKP-1 was barely detectable proba-
bly due to the different time frame of development fromstrated, to our knowledge for the first time, that signaling
molecules are differentially expressed in renal dysplasia. rat kidneys.
While the mechanism of perturbed nephron formationHGF and IGF are known to activate ERK in kidney
epithelial cells [18, 19]. The involvement of ERK in the in renal dysplasia is unknown, the up-regulated ERK or
p38 may play a role. Paradoxically, our previous studysignaling of adhesion molecules also has been demon-
strated [20]. The role of p38 in the cellular signaling of demonstrated that the inhibition of p38 and ERK sup-
pressed mesenchymal-epithelial transformation [10]. Athese growth factors and adhesion molecules is less clear.
Kidney malformations result from gene abnormality, ob- similar scheme has been demonstrated for PAX2. Thus,
too much PAX2 leads to renal dysplasia, whereas toostruction of the urinary tract, maternal malnutrition and
teratogenes [4]. It is conceivable that various extracellu- little PAX2 results in hypoplastic kidney [25]. It is intri-
guing to speculate that ERK or p38 may be involved inlar signals affect MAPKs and lead to altered gene expres-
sion and kidney malformations. Of particular interest, expression of PAX2 or its downstream signaling.
A recent study by Yang et al demonstrated that trans-ERK and p38 have been shown to be activated by cell
stretch in mesangial cells [21, 22]. Urinary tract obstruc- forming growth factor-
 (TGF-
) is up-regulated in hu-
man renal dysplasia [26]. Since TGF-
 is known to en-tion causes renal epithelial cell stretch [23]. It is possible
that urinary tract obstruction may activate ERK or p38 hance epithelial-mesenchymal transformation in various
tissues, the authors suggested that TGF-
 might be re-and lead to the evolution of dysplastic kidneys.
We previously showed that JNK was expressed pre- sponsible for the pathobiology of dysplastic kidneys [26].
Of interest, p38 and ERK have been shown to mediatedominantly in the adult kidney, which suggests that JNK
may be involved in the differentiation at a later stage or TGF-
 secretion stimulated by cell stretch or by high
glucose in mesangial cells [22, 27]. It is possible thatthe maintenance of the integrity of tubular epithelia. In
the present study, normal human kidneys from gestational up-regulated p38 and/or ERK may mediate TGF-
 up-
regulation in dysplastic kidneys.ages 19 to 34 weeks expressed JNK, whereas dysplastic
epithelia including postnatal specimen were completely The present results suggest that MAPKs are dysregu-
lated in human renal dysplasia. Their roles in the patho-negative. Epithelia lacking JNK may fail to differentiate
maintaining high rate proliferation. Alternatively, the genesis of obstructive renal dysplasia are currently under
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Fig. 2. Immunohistochemical localization of mitogen-activated protein kinases (MAPKs) and MAPK phosphatase-1 (MKP-1) in normal and
dysplastic kidneys. Sections A, C, E, G, I, K, and M are from a normal 21-week gestation kidney. B, D, F, H, J, L, and N are from a 22-week
gestation dysplastic kidney. (A-D) Immunohistochemical localization of p38 (400) and P-p38 (200). p38 is not detected in the normal kidney
(A), but strongly expressed in dysplastic epithelia (B). p38-staining is also found in surrounding undifferentiated cells (B). Phospho-p38 (P-p38)
is not detected in the control kidney (C), but is strongly expressed in dysplastic epithelia (D). (E-H) Immunohistochemical localization of JNK
and P-JNK (400). In the normal kidney, JNK is expressed in tubular epithelial cells (E). In contrast, JNK is not expressed in dysplastic tubules
and cysts (F). In the normal kidney, distal tubules show weak staining for P-JNK (G). Dysplastic epithelia are entirely negative for P-JNK (H).
(I-L) Immunohistochemical localization of ERK (400) and P-ERK (200). In the normal kidney, distal tubules and proximal tubules to a lesser
extent stain positive for ERK (I). Immature tubules and non-induced mesenchyme are weakly stained. In the dysplastic kidney, dysplastic tubules,
cystic epithelia, and occasional undifferentiated cells stain positive for ERK (J). In the normal kidney, P-ERK was detected weakly in distal tubules
(K). Dysplastic epithelia stain exclusively positive for P-ERK (L). (M, N) Immunohistochemical localization of MKP-1 (400). In the normal
kidney, faint MKP-1 staining is detected in ureteric bud epithelia (M). In the dysplastic kidney, dysplastic epithelia show strong staining (N).
Surrounding undifferentiated cells are also positive for MKP-1.
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Fig. 2. (Continued)
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